Published in AIDS Weekly, July 15th, 2002
"In the rhesus macaque model, some protection was afforded by DNA/recombinant viral vector vaccines," according to Helen Horton, Wisconsin Regional Primate Research Center, and a multicenter team in the U.S. and Europe and at PowderJect Vaccines, Inc., in Madison, Wisconsin.
However, many HIV strains may not be as vulnerable as the simian strain used in many primate studies, Horton and coauthors found.
Researchers studying candidate vaccines often...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.